Fair Value Measurement - Fair Value of Liabilities Measured on a Recurring Basis (Details) (Fair Value, Measurements, Recurring [Member], USD $)
|
Jun. 30, 2013
|
Dec. 31, 2012
|
---|---|---|
Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]
|
||
Assets: | ||
Derivative instruments | $ 811,084 | $ 0 |
Liabilities: | ||
Derivative instruments | 5,023,026 | 8,214,582 |
Fair Value, Inputs, Level 3 [Member]
|
||
Liabilities: | ||
Contingent consideration | 1,147,408 | 1,147,408 |
Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Liabilities: | ||
Total liabilities | $ 6,170,434 | $ 9,361,990 |
X | ||||||||||
- Definition
Contingent Consideration, Fair Value Disclosure No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Fair values as of the balance sheet date of all assets resulting from contracts that meet the criteria of being accounted for as derivative instruments, net of the effects of master netting arrangements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Derivative instrument obligations meeting the definition of a liability which the Company is a party to as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents the aggregate of the liabilities reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|